The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ps.37.1.27

Although biofeedback was developed by psychologists, it has been most widely used in the treatment of psychophysiological and medical disorders and less frequently used to control symptoms of psychopathology and mental disorders. The authors review studies in which biofeedback was used in the treatment of patients with schizophrenia, depression, anxiety disorders, insomnia, alcobol and drug dependence, and tardive dyskinesia. The studies indicate that biofeedback can help selected patients modify specific responses or response patterns associated with a mental disorder. It appears to be most suitable for patients and disorders in which physiological processes can be identified as relevant. However, the findings offer little support for biofeedback as the treatment of choice for any mental disorder.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.